These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11304652)

  • 1. Effect of activated charcoal on diethylcarbamazine absorption in humans.
    Orisakwe OE; Ilondu ND; Afonne OJ; Ofoefule SI; Orish CN; Agbasi PU
    Am J Ther; 2001; 8(1):7-9. PubMed ID: 11304652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceleration of body clearance of diethylCarbamazine by oral activated charcoal.
    Orisakwe OE; Ilondu NA; Afonne OJ; Ofoefule SI; Orish CN
    Pharmacol Res; 2000 Aug; 42(2):167-70. PubMed ID: 10887047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of activated charcoal on rifampicin absorption in man.
    Orisakwe OE; Dioka CE; Okpogba AN; Orish CN; Ofoefule SI
    Tokai J Exp Clin Med; 1996 Feb; 21(1):51-4. PubMed ID: 9239805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal dialysis of disopyramide in healthy subjects.
    Arimori K; Kawano H; Nakano M
    Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):280-4. PubMed ID: 2737797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil.
    Laine K; Kivistö KT; Neuvonen PJ
    J Toxicol Clin Toxicol; 1997; 35(3):263-8. PubMed ID: 9140320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on transport of disopyramide into the intestinal lumen aimed at gastrointestinal dialysis by activated charcoal in rats.
    Arimori K; Nakano M
    J Pharm Pharmacol; 1989 Jul; 41(7):445-9. PubMed ID: 2570848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of diethylcarbamazine after single oral dose at two different times of day in human subjects.
    Bolla S; Boinpally RR; Poondru S; Devaraj R; Jasti BR
    J Clin Pharmacol; 2002 Mar; 42(3):327-31. PubMed ID: 11865970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP
    Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry.
    Gomez HF; McClafferty HH; Flory D; Brent J; Dart RC
    Ann Emerg Med; 1997 Nov; 30(5):587-92. PubMed ID: 9360566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do gastric contents modify antidotal efficacy of oral activated charcoal?
    Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1984 Nov; 18(5):663-9. PubMed ID: 6508975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of activated charcoal on the pharmacokinetics of pholcodine, with special reference to delayed charcoal ingestion.
    Laine K; Kivistö KT; Ojala-Karlsson P; Neuvonen PJ
    Ther Drug Monit; 1997 Feb; 19(1):46-50. PubMed ID: 9029746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of activated charcoal on phenytoin pharmacokinetics.
    Rowden AM; Spoor JE; Bertino JS
    Ann Emerg Med; 1990 Oct; 19(10):1144-7. PubMed ID: 2221521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of activated charcoal on ethanol blood levels in dogs.
    North DS; Thompson JD; Peterson CD
    Am J Hosp Pharm; 1981 Jun; 38(6):864-6. PubMed ID: 7246560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preadministration of activated charcoal and aspirin absorption.
    McKinney PE; Gillilan R; Watson WA
    J Toxicol Clin Toxicol; 1992; 30(4):549-56. PubMed ID: 1433426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of activated charcoal versus gastric lavage half an hour after ingestion of moclobemide, temazepam, and verapamil.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 2000 Jul; 56(4):285-8. PubMed ID: 10954340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):219-25. PubMed ID: 2987139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of oral activated charcoal on imipramine clearance.
    Goldberg MJ; Park GD; Spector R; Fischer LJ; Feldman RD
    Clin Pharmacol Ther; 1985 Sep; 38(3):350-3. PubMed ID: 4028632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of activated charcoal-sodium sulfate combination for inhibition of acetaminophen absorption and repletion of inorganic sulfate.
    Galinsky RE; Levy G
    J Toxicol Clin Toxicol; 1984 Jul; 22(1):21-30. PubMed ID: 6492228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cholestyramine and activated charcoal on glipizide absorption.
    Kivistö KT; Neuvonen PJ
    Br J Clin Pharmacol; 1990 Nov; 30(5):733-6. PubMed ID: 2271372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.